iohexol has been researched along with Angiofollicular Lymph Hyperplasia in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YF | 1 |
| Zhang, WD | 1 |
| Sun, CZ | 1 |
| Ouyang, D | 1 |
| Chen, WK | 1 |
| Luo, RZ | 1 |
| Wu, MW | 1 |
1 other study available for iohexol and Angiofollicular Lymph Hyperplasia
| Article | Year |
|---|---|
Clinical features and outcomes of head and neck castleman disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Chemotherapy, | 2012 |